Prostate Cancer Connect
  • Saved

Irreversible electroporation augments checkpoint immunotherapy in prostate cancer and promotes tumor antigen-specific tissue-resident memory CD8+ T cells - PubMed

Irreversible electroporation augments checkpoint immunotherapy in prostate cancer and promotes tumor antigen-specific tissue-resident memory CD8+ T cells - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34162858/

Memory CD8+ T cells populate non-lymphoid tissues (NLTs) following pathogen infection, but little is known about the establishment of endogenous tumor-specific tissue-resident memory T cells (T RM ) during cancer...

  • Saved

Multi-institutional retrospective analysis of ultrahypofractionated radiotherapy for Japanese prostate cancer patients - PubMed

Multi-institutional retrospective analysis of ultrahypofractionated radiotherapy for Japanese prostate cancer patients - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34162908/

To report outcomes and risk factors of ultrahypofractionated (UHF) radiotherapy for Japanese prostate cancer patients. This multi-institutional retrospective analysis comprised 259 patients with localized prostate cancer from 6 hospitals. A...

  • Saved

miR-593-3p Promotes Proliferation and Invasion in Prostate Cancer Cells by Targeting ADIPOR1 - PubMed

miR-593-3p Promotes Proliferation and Invasion in Prostate Cancer Cells by Targeting ADIPOR1 - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34163175/

1 Department of Nephrology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, People's Republic of China. 2 Department of Cardiovascular Medicine, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou,...

  • Saved

High-dose-rate brachytherapy for prostate cancer: Rationale, current applications, and clinical outcome - PubMed

High-dose-rate brachytherapy for prostate cancer: Rationale, current applications, and clinical outcome - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34164950/

Valid long-term data, both in regard to the oncologic outcomes and toxicity profile, support the current clinical indication spectrum of HDR BRT. At the same time, this serves as solid,...